The company reported FY2025 sales of $1.522 billion with net income of $49.3 million and adjusted EBITDA of $156.8 million. AdvanSix completed planned turnarounds, generated positive free cash flow, and expects 2026 capex of $75–95 million.
Cyborg Score Rationale
According to analysts, AdvanSix has an average rating of "Buy" with a 12-month stock price target of $25.5, which is 35.86% higher than the latest price. The company demonstrates solid fundamentals with stable earnings, a 3.6% dividend yield, and strategic positioning in essential chemistry markets, though faces cyclical headwinds in nylon demand.
Top Insights
Plant Nutrients represent the largest segment at 38% of total sales, followed by Chemical Intermediates at 26%, Nylon at 20%, and Caprolactam at 16%.
Q2 2025 results included $8 million in 45Q carbon capture tax credits, demonstrating monetization of environmental assets.
Over the past 52 weeks, ASIX has traded between $14.10 and $28.46, showing significant volatility.
The company announced a cash dividend of $0.16 with an ex-date of March 9, 2026.
Named Competitors
Nylon Resins & Polymers — Large diversified petrochemical producer with significant polymer operations
Specialty Chemicals & Fertilizers — Diversified chemicals and materials company with fertilizer operations
Advanced Materials — Producer of specialty chemicals and advanced materials